Información:
Error:
ID
34724
Descripción
Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136); ODM derived from: https://clinicaltrials.gov/show/NCT01545388
Link
https://clinicaltrials.gov/show/NCT01545388
Palabras clave
Versiones (1)
- 25/1/19 25/1/19 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
25 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Type 2 Diabetes Mellitus NCT01545388
Eligibility Type 2 Diabetes Mellitus NCT01545388
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01545388
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus (t2dm)
boolean
C0011860 (UMLS CUI [1])
Diet therapy | Exercise | Sitagliptin Dose Stable | Oral hypoglycemic | Hemoglobin A1c measurement
Item
currently being treated with diet/exercise and on stable dose of sitagliptin for ≥ 4 weeks, on any additional oral hypoglycemic agent (aha) in the prior 8 weeks, and hba1c ≥ 6.0% and ≤ 9.0%; or
boolean
C0012159 (UMLS CUI [1])
C0015259 (UMLS CUI [2])
C1565750 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0359086 (UMLS CUI [4])
C0474680 (UMLS CUI [5])
C0015259 (UMLS CUI [2])
C1565750 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0359086 (UMLS CUI [4])
C0474680 (UMLS CUI [5])
Diet therapy | Exercise | Sitagliptin Dose Stable | Oral hypoglycemic Absent | Hemoglobin A1c measurement
Item
currently being treated with diet/exercise and on stable dose of sitagliptin for ≥ 10 weeks, not on any additional oral aha in the prior 8 weeks, and hba1c ≥ 6.5% and < 10.0%
boolean
C0012159 (UMLS CUI [1])
C0015259 (UMLS CUI [2])
C1565750 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0359086 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0474680 (UMLS CUI [5])
C0015259 (UMLS CUI [2])
C1565750 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0359086 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0474680 (UMLS CUI [5])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus,
boolean
C0011854 (UMLS CUI [1])
Secondary diabetes mellitus
Item
secondary diabetes mellitus, or
boolean
C0271640 (UMLS CUI [1])
Gestational Diabetes
Item
gestational diabetes mellitus
boolean
C0085207 (UMLS CUI [1])